Biography
Dr. Yong Moon Choi completed his PhD from the State University of New York and his postdoctoral studies from Purdue University under 1979 Nobel Laureate Herbert C. Brown. He is currently the president and CEO of Bio-Pharm Solutions, based in South Korea. He founded SK Biopharmaceuticals (New Jersey, Seoul/DIT, Shanghai) in 1993, and while there, Dr. Choi discovered and developed drug candidates for central nervous system (CNS) disorders. Under Dr. Choi's leadership, SK Biopharmaceuticals was the first Korean company to receive an IND by the US FDA (YKP10A), and in total, Dr. Choi has received 10 IND's from the US FDA.
Research Interest
.
Biography
Daniel Cohen , MD Phd, former Professor of Medical Genetics in Paris University has authored more than 150 peer reviewed papers in hire wired Journal , including the first integrated map of the Human Genome back in the 90’s. While he has discovered or co discovered numerous genes for rare and common diseases, he has also pioneered several key technologies like Large Scale Biology at Genethon, he cofounded in France, but also Pharmacogenomics, Genome Wide Association Studies and Network Pharmacology. He was a confounder of Millenium pharmaceuticals in Boston, MA. He is now Chairman, CEO and cofounder of the France Based company, Pharnext, focusing on treatment of unmet Neurodegenerative disorders by using Network Pharmacology.
Research Interest
orphan genetic
Biography
Serge Braun, PharmD, is Scientific Director of AFM-Telethon since 2005, the French Muscular dystrophy Association, and President of Genosafe, a CRO company dedicate to QC of biotherapeutic products. He obtained his degree in Pharmacy and a Ph.D in Pharmacology from the Louis Pasteur University of Strasbourg, France; was a postdoctoral fellow at the Neuromuscular Center, School of Medicine of the University of Southern California in Los Angeles, USA.
Research Interest
.